What one share of Silo Pharma holds
We are focused on developing novel therapies that include conventional drugs and psychedelic
Silo Pharma’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.06 |
|---|---|
| Profit | −$5.08 |
| Cash and investments | $2.90 |
| Book value | $4.33 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2018 | — | −$14.81 | — | — | — | — |
| 2019 | $1.30 | −$30.00 | — | — | — | −$0.73 |
| 2020 | $0.47 | −$37.50 | — | — | — | $11.28 |
| 2021 | — | $30.52 | — | — | — | $68.91 |
| 2022 | $0.47 | −$25.67 | — | — | — | $49.10 |
| 2023 | $0.35 | −$18.02 | — | — | — | $31.88 |
| 2024 | $0.29 | −$17.90 | — | — | — | $16.84 |
| 2025 | $0.13 | −$7.57 | — | — | — | $7.10 |
Common questions about Silo Pharma
How much does one share of Silo Pharma earn?
Over the last 12 months, Silo Pharma lost $5.08 for each share on $0.06 of sales.
Does Silo Pharma pay a dividend?
Silo Pharma didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Silo Pharma’s book value per share?
Silo Pharma’s book value is $4.33 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Silo Pharma have?
Each share of Silo Pharma has $2.90 of cash and investments, as of June 30, 2026.
Has Silo Pharma bought back shares?
Silo Pharma’s share count rose about 754% from 2018 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.